One-pot synthesis of new triazole - Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity

dc.contributor.authorRamprasad, J.
dc.contributor.authorNayak, N.
dc.contributor.authorUdayakumar, D.
dc.contributor.authorYogeeswari, P.
dc.contributor.authorSriram, D.
dc.date.accessioned2020-03-31T08:39:08Z
dc.date.available2020-03-31T08:39:08Z
dc.date.issued2015
dc.description.abstractA new series of triazole-imidazo[2,1-b][1,3,4]thiadiazole hybrids (6a-s, 7a) were designed by a molecular hybridisation approach and the target molecules were synthesized via one pot click chemistry protocol. All the intermediates and final molecules were characterised using spectral methods and one of the target compounds (6c) was analysed by the single crystal XRD study. The derivatives were screened for their antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain. Two compounds, 6f and 6n, demonstrated significant growth inhibitory activity against the bacterial strain with a MIC of 3.125 ?g/mL. The presence of chloro substituent on the imidazo[2,1-b][1,3,4]thiadiazole ring and ethyl, benzyl or cyanomethylene groups on the 1,2,3-triazole ring enhance the inhibition activity of the molecules. The active compounds are not toxic to a normal cell line which signifies the lack of general cellular toxicity of these compounds. 2015 Elsevier Ltd. All rights reserved.en_US
dc.identifier.citationBioorganic and Medicinal Chemistry Letters, 2015, Vol.25, 19, pp.4169-4173en_US
dc.identifier.urihttps://idr.nitk.ac.in/jspui/handle/123456789/12387
dc.titleOne-pot synthesis of new triazole - Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activityen_US
dc.typeArticleen_US

Files